Jaguar Health (JAGX) vs MetaVia (MTVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
MetaVia is the larger company by market cap ($9.0 million vs $8.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | JAGX | MTVA |
|---|---|---|
| Share price | $4.43 | $1.36 |
| Market cap | $8.63M | $8.96M |
| 1-day change | -11.33% | -6.85% |
| EPS (TTM) | $-4,012.65 | $-3.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1,267.88 | $14.85 |
| 52-week low | $2.35 | $0.966 |
| Distance from 52-week high | -99.65% | -90.84% |
| Average volume | 2.00M | 230.88K |
| Shares outstanding | 1.95M | 6.59M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
JAGX vs MTVA FAQ
Which is bigger, Jaguar Health or MetaVia?
MetaVia (MTVA) is larger, with a market capitalization of $8.96M compared with $8.63M for Jaguar Health (JAGX).
Are Jaguar Health and MetaVia in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.